[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
  HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule

Tentative Approvals - July 2004

  ANDA Number Generic Drug Name Applicant Tentative Approval Date
1 76-706 METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS 500 MG   APOTEX INC. 7/1/2004 
2 76-236 FEXOFENADINE HCL & PSEUDOEPHEDRINE HCL EXTENDED-RELEASE TABL 60 MG/120 MG   BARR LABORATORIES, INC. 7/1/2004 
3 76-591 MOMETASONE FUROATE CREAM, USP 0.1%   ATRIX LABORATORIES, INC. 7/13/2004 
4 76-540 SERTRALINE HYDROCHLORIDE TABLETS 25 MG (BASE), 50 MG (BASE), AND 100 MG (BASE)   GENPHARM INC. 7/14/2004 
5 76-651 QUINAPRIL HYDROCHLORIDE TABLETS 5 MG (BASE), 10 MG (BASE), 20 MG (BASE), AND 40 MG (BASE)   MUTUAL PHARMACEUTICAL COMPANY, INC. 7/15/2004 
6 76-665 FLUCONAZOLE TABLETS 50 MG, 100 MG, 150 MG, AND 200 MG   APOTEX INC. 7/20/2004 
7 76-573 ESMOLOL HYDROCHLORIDE INJECTION 10 MG/ML; PACKAGED IN 100 MG/10 ML SINGLE-DOSE VIALS   AMERICAN PHARMACEUTICAL PARTNERS, INC. 7/20/2004 
8 76-871 MITOXANTRONE INJECTION, USP (CONCENTRATE) 2 MG/ML; PACKAGED IN 20 MG/10 ML, 25 MG/12.5 ML, AND 30 MG/15 ML MULTIPLE-DOSE VIALS   MAYNE PHARMA (USA) INC. 7/23/2004 
9 76-731 GLYBURIDE AND METFORMIN HYDROCHLORIDE TABLETS 1.25 MG/250 MG, 2.5 MG/500 MG, AND 5 MG/500 MG   COREPHARMA LLC 7/30/2004 

Back to Top     Back to Approvals

Date created: August 4, 2004

horizonal rule